IOP must be monitored in refractive surgery patients

Article

In eyes that have undergone corneal refractive surgery, non-Goldmann measurements of intraocular pressure (IOP) and continued examination of the optic nerve is essential as changes of the corneal shape can lead to falsely low IOP values.

In eyes that have undergone corneal refractive surgery, non-Goldmann measurements of intraocular pressure (IOP) and continued examination of the optic nerve is essential as changes of the corneal shape can lead to falsely low IOP values, according to a report published in the January issue of the Journal of Refractive Surgery.

Alexander Friedrich Scheuerle and colleagues from the University of Heidelberg, Germany, reported on a case of advanced glaucomatous optic atrophy years after bilateral radial keratotomy in a 40-year old woman.

Multiple IOP measurements of both eyes were obtained using Goldmann applanation tonometry as well as air-puff and Schiotz tonometry. In addition to regular eye examinations, corneal thickness, surface and shape were examined using Orbscan and C-scan.

The cornea of both eyes did not show signs of thinning but flattening of the corneal surface was observed. The decreased corneal curvatures precipitated a misjudgement of IOP readings measured by central applanantion tonometry (12 to 18 mmHg), whereas impression and non-contact tonometry revealed elevated IOP values (21 to 27 mmHg).

The authors believe that changes in corneal shape, without corneal thinning, can lead to falsely low IOP values and therefore, in eyes that have undergone corneal refractive surgery, non-Goldmann measurements and continued examinations of the optic nerve are recommended.

Recent Videos
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
© 2024 MJH Life Sciences

All rights reserved.